Business Description
FibroGen Inc
NAICS : 325412
SIC : 2834
ISIN : US31572Q8087
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.54 | |||||
Equity-to-Asset | -0.48 | |||||
Debt-to-Equity | -0.75 | |||||
Debt-to-EBITDA | -0.58 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -7.41 | |||||
Beneish M-Score | -0.85 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.2 | |||||
3-Year EBITDA Growth Rate | -13.7 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 11.53 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.96 | |||||
9-Day RSI | 25.22 | |||||
14-Day RSI | 32.69 | |||||
6-1 Month Momentum % | 314.95 | |||||
12-1 Month Momentum % | -87.8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.52 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 1.08 | |||||
Days Inventory | 799.1 | |||||
Days Sales Outstanding | 51.28 | |||||
Days Payable | 588.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.6 | |||||
Shareholder Yield % | -81.29 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 87.24 | |||||
Operating Margin % | -182.2 | |||||
Net Margin % | -192.37 | |||||
FCF Margin % | -215.27 | |||||
ROA % | -55.78 | |||||
ROIC % | -188.42 | |||||
ROC (Joel Greenblatt) % | -298.78 | |||||
ROCE % | -97.03 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.76 | |||||
EV-to-EBIT | -0.1 | |||||
EV-to-EBITDA | -0.11 | |||||
EV-to-Revenue | 0.2 | |||||
EV-to-FCF | -0.1 | |||||
Earnings Yield (Greenblatt) % | -973.25 | |||||
FCF Yield % | -284.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
FibroGen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 137.172 | ||
EPS (TTM) (€) | -2.72 | ||
Beta | 1.8 | ||
Volatility % | 198.86 | ||
14-Day RSI | 32.69 | ||
14-Day ATR (€) | 0.102781 | ||
20-Day SMA (€) | 1.580625 | ||
12-1 Month Momentum % | -87.8 | ||
52-Week Range (€) | 0.238 - 18 | ||
Shares Outstanding (Mil) | 98.77 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
FibroGen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
FibroGen Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
FibroGen Inc Frequently Asked Questions
What is FibroGen Inc(FRA:1FG)'s stock price today?
When is next earnings date of FibroGen Inc(FRA:1FG)?
Does FibroGen Inc(FRA:1FG) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |